Angion Biomedica Corp
12 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis (NCT05387785) | Angion Biomedica Corp | 2022-06-01 |
| Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease (NCT04939116) | Angion Biomedica Corp | 2021-12-24 |
| Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects (NCT04958187) | Angion Biomedica Corp | 2021-07-01 |
| Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval (NCT04898907) | Angion Biomedica Corp | 2021-06-01 |
| A Study to Assess the Absorption, Metabolism and Excretion of [14C]-ANG-3777 (NCT04931524) | Angion Biomedica Corp | 2021-05-21 |
| Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia (NCT04459676) | Angion Biomedica Corp | 2020-07-31 |
| ANG-3070 in Healthy Adult Participants (NCT04196179) | Angion Biomedica Corp | 2019-12-17 |
Track Angion Biomedica Corp automatically
Every clearance here is in the API, with alerts when new ones post.